These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 22158723)

  • 1. An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis.
    Prajapati VK; Awasthi K; Yadav TP; Rai M; Srivastava ON; Sundar S
    J Infect Dis; 2012 Jan; 205(2):333-6. PubMed ID: 22158723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted killing of Leishmania donovani in vivo and in vitro with amphotericin B attached to functionalized carbon nanotubes.
    Prajapati VK; Awasthi K; Gautam S; Yadav TP; Rai M; Srivastava ON; Sundar S
    J Antimicrob Chemother; 2011 Apr; 66(4):874-9. PubMed ID: 21393222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania species, drug unresponsiveness and visceral leishmaniasis in Bihar, India.
    Thakur CP; Dedet JP; Narain S; Pratlong F
    Trans R Soc Trop Med Hyg; 2001; 95(2):187-9. PubMed ID: 11355558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.
    Sánchez-Brunete JA; Dea MA; Rama S; Bolás F; Alunda JM; Raposo R; Méndez MT; Torrado-Santiago S; Torrado JJ
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3246-52. PubMed ID: 15328080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization and evaluation of amine-modified graphene amphotericin B for the treatment of visceral leishmaniasis: in vivo and in vitro studies.
    Mudavath SL; Talat M; Rai M; Srivastava ON; Sundar S
    Drug Des Devel Ther; 2014; 8():1235-47. PubMed ID: 25214767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and antileishmanial activity of amphotericin B-loaded stable ionic amphiphile biovector formulations.
    Loiseau PM; Imbertie L; Bories C; Betbeder D; De Miguel I
    Antimicrob Agents Chemother; 2002 May; 46(5):1597-601. PubMed ID: 11959611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinspired Calcium Phosphate Nanoparticles Featuring as Efficient Carrier and Prompter for Macrophage Intervention in Experimental Leishmaniasis.
    Chaurasia M; Singh PK; Jaiswal AK; Kumar A; Pawar VK; Dube A; Paliwal SK; Chourasia MK
    Pharm Res; 2016 Nov; 33(11):2617-29. PubMed ID: 27401407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.
    Gupta S; Dube A; Vyas SP
    J Drug Target; 2007 Jul; 15(6):437-44. PubMed ID: 17613662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the potential of polyester nanoparticles for per oral delivery of amphotericin B in treating visceral leishmaniasis.
    Italia JL; Kumar MN; Carter KC
    J Biomed Nanotechnol; 2012 Aug; 8(4):695-702. PubMed ID: 22852479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self assembled ionically sodium alginate cross-linked amphotericin B encapsulated glycol chitosan stearate nanoparticles: applicability in better chemotherapy and non-toxic delivery in visceral leishmaniasis.
    Gupta PK; Jaiswal AK; Asthana S; Verma A; Kumar V; Shukla P; Dwivedi P; Dube A; Mishra PR
    Pharm Res; 2015 May; 32(5):1727-40. PubMed ID: 25425053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India.
    Murray HW
    Future Microbiol; 2010 Sep; 5(9):1301-3. PubMed ID: 20860475
    [No Abstract]   [Full Text] [Related]  

  • 12. Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.
    Wasan KM; Wasan EK; Gershkovich P; Zhu X; Tidwell RR; Werbovetz KA; Clement JG; Thornton SJ
    J Infect Dis; 2009 Aug; 200(3):357-60. PubMed ID: 19545212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
    Berman JD; Ksionski G; Chapman WL; Waits VB; Hanson WL
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1978-80. PubMed ID: 1416890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.
    Gupta PK; Asthana S; Jaiswal AK; Kumar V; Verma AK; Shukla P; Dwivedi P; Dube A; Mishra PR
    Bioconjug Chem; 2014 Jun; 25(6):1091-102. PubMed ID: 24842628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.
    Khatik R; Dwivedi P; Khare P; Kansal S; Dube A; Mishra PR; Dwivedi AK
    Expert Opin Drug Deliv; 2014 May; 11(5):633-46. PubMed ID: 24606222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.
    Gangneux JP; Sulahian A; Garin YJ; Farinotti R; Derouin F
    Antimicrob Agents Chemother; 1996 May; 40(5):1214-8. PubMed ID: 8723469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan coated PluronicF127 micelles for effective delivery of Amphotericin B in experimental visceral leishmaniasis.
    Singh PK; Pawar VK; Jaiswal AK; Singh Y; Srikanth CH; Chaurasia M; Bora HK; Raval K; Meher JG; Gayen JR; Dube A; Chourasia MK
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):1220-1231. PubMed ID: 28780414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters.
    Maes L; Germonprez N; Quirijnen L; Van Puyvelde L; Cos P; Vanden Berghe D
    Antimicrob Agents Chemother; 2004 Jun; 48(6):2056-60. PubMed ID: 15155199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.
    Asthana S; Jaiswal AK; Gupta PK; Pawar VK; Dube A; Chourasia MK
    Antimicrob Agents Chemother; 2013 Apr; 57(4):1714-22. PubMed ID: 23357762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amphotericin-B colloidal dispersion. A review of its use against systemic fungal infections and visceral leishmaniasis.
    Brogden RN; Goa KL; Coukell AJ
    Drugs; 1998 Sep; 56(3):365-83. PubMed ID: 9777313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.